Sign inCreate account

Report workspace tools

NCT02239523COMPLETEDanonymous

Management Strategies by an Orthopedic Department to Improve the Evaluation and Treatment of Osteoporosis.

Sponsor

Source record

Shaare Zedek Medical Center

Phase

Source record

NA

Modality

AI-normalized

monoclonal antibody

Target

AI-normalized

Osteoporosis management after hip fracture

Indication / condition

AI-normalized

Osteoporotic Fracture

Intervention

Source record

Letter Group, Intervention Group

Source & freshness

Source record

NCT ID

NCT02239523

Original source

ClinicalTrials.gov

Source last updated

Apr 05, 2019

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02239523

Title

Management Strategies by an Orthopedic Department to Improve the Evaluation and Treatment of Osteoporosis.

Sponsor

Shaare Zedek Medical Center

Status

COMPLETED

Phase

NA

Condition raw

Osteoporotic Fracture

Condition normalized

Osteoporotic Fracture

Modality raw

Osteoporotic Fracture

Modality normalized

monoclonal antibody

Target raw

Osteoporosis management after hip fracture

Target normalized

Osteoporosis management after hip fracture

Interventions

Letter Group, Intervention Group

Public preview

Source record

This clinical trial evaluates the effectiveness of orthopedic interventions in managing osteoporosis in patients with fragility fractures. It aims to improve treatment adherence and conduct a cost-benefit analysis of the interventions. The study was conducted at Shaare Zedek Medical Center and involved 200 patients over 50 years old.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Management Strategies by an Orthopedic Department to Improve the Evaluation and Treatment of Osteoporosis.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02239523

Status

COMPLETED

Phase

NA

Sponsor

Shaare Zedek Medical Center

Executive brief

Investment-Ready Snapshot

This clinical trial evaluates the effectiveness of orthopedic interventions in managing osteoporosis in patients with fragility fractures. It aims to improve treatment adherence and conduct a cost-benefit analysis of the interventions. The study was conducted at Shaare Zedek Medical Center and involved 200 patients over 50 years old.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedApr 05, 2019
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02239523

Indication

Osteoporotic Fracture

Modality

monoclonal antibody

Target

Osteoporosis management after hip fracture

Intervention

Letter Group, Intervention Group

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.